Allspring Global Investments Holdings LLC Decreases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Allspring Global Investments Holdings LLC cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 154,318 shares of the exchange traded fund’s stock after selling 9,142 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.20% of SPDR S&P Biotech ETF worth $13,898,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Hartline Investment Corp raised its stake in SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after buying an additional 106 shares in the last quarter. Signature Estate & Investment Advisors LLC grew its position in SPDR S&P Biotech ETF by 5.7% during the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after purchasing an additional 125 shares during the period. Denver Wealth Management Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 0.9% during the 3rd quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock valued at $1,460,000 after purchasing an additional 127 shares in the last quarter. Graypoint LLC raised its holdings in SPDR S&P Biotech ETF by 5.6% in the 3rd quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock worth $271,000 after purchasing an additional 146 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in SPDR S&P Biotech ETF by 0.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock valued at $2,373,000 after purchasing an additional 148 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $91.41 on Tuesday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a market capitalization of $6.97 billion, a PE ratio of 11.47 and a beta of 1.11. The business’s 50 day moving average price is $91.63 and its 200-day moving average price is $96.06.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.